Cochrane Abstracts
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV‐negative people at risk of active TB
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rifamycins (rifampicin, Rifabutin and Rifapentine) Compared to Isoniazid for Preventing Tuberculosis in HIV‐negative People at Risk of Active TB." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433809/all/Rifamycins__rifampicin__rifabutin_and_rifapentine__compared_to_isoniazid_for_preventing_tuberculosis_in_HIV_negative_people_at_risk_of_active_TB:_Cochrane_systematic_review.
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV‐negative people at risk of active TB. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433809/all/Rifamycins__rifampicin__rifabutin_and_rifapentine__compared_to_isoniazid_for_preventing_tuberculosis_in_HIV_negative_people_at_risk_of_active_TB:_Cochrane_systematic_review. Accessed July 19, 2026.
Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV‐negative people at risk of active TB. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433809/all/Rifamycins__rifampicin__rifabutin_and_rifapentine__compared_to_isoniazid_for_preventing_tuberculosis_in_HIV_negative_people_at_risk_of_active_TB:_Cochrane_systematic_review
Rifamycins (rifampicin, Rifabutin and Rifapentine) Compared to Isoniazid for Preventing Tuberculosis in HIV‐negative People at Risk of Active TB [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 July 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433809/all/Rifamycins__rifampicin__rifabutin_and_rifapentine__compared_to_isoniazid_for_preventing_tuberculosis_in_HIV_negative_people_at_risk_of_active_TB:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV‐negative people at risk of active TB
ID - 433809
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433809/all/Rifamycins__rifampicin__rifabutin_and_rifapentine__compared_to_isoniazid_for_preventing_tuberculosis_in_HIV_negative_people_at_risk_of_active_TB:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
